课题基金 / 基金详情

HYPOHXANTHINE GUANINE PHOSPHORIBOSYL TRANSFERASE: FOR NEW MALARIA CHEMOTHERAPIES

HYPOHXANTHINE GUANINE PHOSPHORIBOSYL TRANSFERASE: FOR NEW MALARIA CHEMOTHERAPIES
次黄嘌呤鸟嘌呤磷酸核糖基转移酶:用于新的疟疾化疗
批准号:
6205797
负责人:
STEVE ALMO
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2000-08-31

项目摘要

项目成果

STEVE ALMO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase (HPPK) has been expressed from E. coli. It is the first enzyme in folate synthesis. Unlike mammalian cells that take up folate cofactors from the diet, most microorganisms must synthesize folates de novo, since they lack the transport pathway. For this reason, HPPK is important as a potential target for selective antimicrobial chemotherapy. Data for native protein have been collected at 1.6 E resolution (space group P21, a=36.3 E, b=51.9 E, c=41.2 E, =110.3 , Rsym=4.4%). Other data collected: HPPK / MgATP complex: single wavelength data at 1.6 A. HPPK / HP complex: single wavelength data at 2.1 A.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STRUCT OF EVH1, TARGETING MODULE FOR SITE SPECIFIC ACTIN FILAMENT ASSEMBLY
PURINE NUCLEOSIDE PHOSPHORYLASE & NEW CHEMOTHERAPIES FOR LYMPHOMA & GRAFT REJECT
SYNCHROTRON CRYSTALLOGRAPHY BEAMLINE X9A STRUCTURE FUNCTION STUDIES
ACTIVE SITE TARGETING OF PROTEIN TYROSINE PHOSPHATASES BY SYNCH CRYSTALLOGRAPHY
海外基金